中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2008年
9期
633-637
,共5页
颈动脉狭窄%安替比林%血管成形术,气囊%手术后并发症%明胶酶A%大鼠
頸動脈狹窄%安替比林%血管成形術,氣囊%手術後併髮癥%明膠酶A%大鼠
경동맥협착%안체비림%혈관성형술,기낭%수술후병발증%명효매A%대서
Carotid stenosis%Antipyrine%Angioplasty,balloon%Postoperative complications%gelatinase A%Rats
目的 观察依达拉奉对大鼠颈动脉损伤后再狭窄的防治作用,并探讨其作用机制.方法 雄性SD大鼠用数字表法随机分为两组:对照组和治疗组各20只.用2F球囊对大鼠右侧颈总动脉内膜损伤法制作再狭窄模型.治疗组制模后给予依达拉奉3 mg/kg,静脉注射,每日2次.对照组损伤后给予等体积的生理盐水.损伤后1、3、7、14和28 d原位灌注固定取材,分析病理形态学改变及采用免疫组织化学方法观察基质金属蛋白酶-2(MMP-2)的表达.结果 对照组损伤侧动脉14和28 d内膜面积分别为(0.240±0.043)mm2和(0.420±0.063)mm2,内膜增生指数为0.52±0.06和0.67±0.07,狭窄率为30%±9%和54%±9%,治疗组内膜面积分别为(0.063±0.025)mm2和(0.116±0.023)mm2,内膜增生指数为0.24±0.07和0.38±0.05,狭窄率为8%±3%和16%±4%,与对照组同一时间点比较,治疗组内膜面积减少(F分别为50.488和81.119),内膜增生指数(F分别为41.743和48.122)和狭窄率减轻(F分别为24.221和76.453,均P<0.05);MMP-2的表达术后3、7、14 d增加,阳性细胞率(%)对照组分别为27.16±7.15、22.59±6.68、18.85±4.91,治疗组为15.57±3.62、12.91±1.88、11.96±3.12,治疗组3、7 d MMP-2表达较对照组下降,差异有统计学意义(F=8.359.P=0.028和F=7.781,P=0.032).结论 依达拉奉可抑制大鼠颈动脉损伤后再狭窄,这种作用与其抑制MMP-2的表达有关.
目的 觀察依達拉奉對大鼠頸動脈損傷後再狹窄的防治作用,併探討其作用機製.方法 雄性SD大鼠用數字錶法隨機分為兩組:對照組和治療組各20隻.用2F毬囊對大鼠右側頸總動脈內膜損傷法製作再狹窄模型.治療組製模後給予依達拉奉3 mg/kg,靜脈註射,每日2次.對照組損傷後給予等體積的生理鹽水.損傷後1、3、7、14和28 d原位灌註固定取材,分析病理形態學改變及採用免疫組織化學方法觀察基質金屬蛋白酶-2(MMP-2)的錶達.結果 對照組損傷側動脈14和28 d內膜麵積分彆為(0.240±0.043)mm2和(0.420±0.063)mm2,內膜增生指數為0.52±0.06和0.67±0.07,狹窄率為30%±9%和54%±9%,治療組內膜麵積分彆為(0.063±0.025)mm2和(0.116±0.023)mm2,內膜增生指數為0.24±0.07和0.38±0.05,狹窄率為8%±3%和16%±4%,與對照組同一時間點比較,治療組內膜麵積減少(F分彆為50.488和81.119),內膜增生指數(F分彆為41.743和48.122)和狹窄率減輕(F分彆為24.221和76.453,均P<0.05);MMP-2的錶達術後3、7、14 d增加,暘性細胞率(%)對照組分彆為27.16±7.15、22.59±6.68、18.85±4.91,治療組為15.57±3.62、12.91±1.88、11.96±3.12,治療組3、7 d MMP-2錶達較對照組下降,差異有統計學意義(F=8.359.P=0.028和F=7.781,P=0.032).結論 依達拉奉可抑製大鼠頸動脈損傷後再狹窄,這種作用與其抑製MMP-2的錶達有關.
목적 관찰의체랍봉대대서경동맥손상후재협착적방치작용,병탐토기작용궤제.방법 웅성SD대서용수자표법수궤분위량조:대조조화치료조각20지.용2F구낭대대서우측경총동맥내막손상법제작재협착모형.치료조제모후급여의체랍봉3 mg/kg,정맥주사,매일2차.대조조손상후급여등체적적생리염수.손상후1、3、7、14화28 d원위관주고정취재,분석병리형태학개변급채용면역조직화학방법관찰기질금속단백매-2(MMP-2)적표체.결과 대조조손상측동맥14화28 d내막면적분별위(0.240±0.043)mm2화(0.420±0.063)mm2,내막증생지수위0.52±0.06화0.67±0.07,협착솔위30%±9%화54%±9%,치료조내막면적분별위(0.063±0.025)mm2화(0.116±0.023)mm2,내막증생지수위0.24±0.07화0.38±0.05,협착솔위8%±3%화16%±4%,여대조조동일시간점비교,치료조내막면적감소(F분별위50.488화81.119),내막증생지수(F분별위41.743화48.122)화협착솔감경(F분별위24.221화76.453,균P<0.05);MMP-2적표체술후3、7、14 d증가,양성세포솔(%)대조조분별위27.16±7.15、22.59±6.68、18.85±4.91,치료조위15.57±3.62、12.91±1.88、11.96±3.12,치료조3、7 d MMP-2표체교대조조하강,차이유통계학의의(F=8.359.P=0.028화F=7.781,P=0.032).결론 의체랍봉가억제대서경동맥손상후재협착,저충작용여기억제MMP-2적표체유관.
Objective To investigate edaravane in prevention of restenosis in rat common catery arteries balloon angioplasty and the possible mechanism of this process. Methods Forty male SD rats were randomly divided into 2 groups: treatment group (whose intima was injured by balloon and was given edaravone 3 mg/kg by peritoneal injection, bid) and control group (whose intima was injured by ballon and was given the same volume NS as edaravone). 1, 3, 7, 14 and 28 days after angioplasty, rats were killed and the local arteries were sectioned for analysis of pathological morphology and the expression of matrix metalloproteinase-2 (MMP-2) analyzed by immunohistochemistry. Results Small amounts of smooth muscle cell appeared at the intima of blood vessel 3 days after the artery injured by balloon. Consecutive intima was formed 7 days after artery injury. The intima was even or uneven thickened and the lumen of artery was significant stenosed 14 and 28 days afterwards. In the control group, the intimal area reached (0.240±0.043) mm2, the intima hyperplasy index were 0.52±0.06, stenosis ratio were 30%±9% 14 days afterwards. The intimal area were (0.420±0.063 )mm2, the intima hyperplasy index were 0.67± 0.07, stenosis ratio were 54%±9% on day 28. In the treatment group, the intimal area were (0.063± 0.025)mm2, the intima hyperplasy index were 0.24±0.07, stenosis ratio were 8%±3% after 14 days. The intimal area were (0.116±0.023) mm2, the intima hyperplasy index were 0.38±0.05, stenosis ratio were 16%±4% after 28 days. Compared with control group at the same time, the intimal area (F values were 50.488 and 81.119 respectively, P < 0.05 ), the intima hyperplasy index ( F values were 41.743 and 48.122 respectively, P<0.05) and stenosis ratio (F values were 24.221 and 81.119 respectively, P< 0.05) were decreased in treatment group. The expressions of MMP-2 raised after balloon injury. In control group, the expressions of MMP-2 were 27.16%±7.15% after 3 days, 22.59%±6.68% after 7 days, 18.85%±4.91% after 14 days. In the treatment group, it decreased to 15.57%±3.62% after 3 days, 12.91%±1.88% after 7 days. Compared with control group, the expressions of MMP-2 in treatment group were lower after 3 days and 7 days ( F = 8.359, P = 0.028 and F = 7.781, P = 0.032 ). Conclusions Edaravone can prevent restenosis in rat common catery after balloon angioplasty. The possible mechanism is that edaravone can inhibit the expressions of MMP-2 in this process.